FDA product code JLZ: Nadh, Phosphoglycerate Mutase, Atp (U.V.) 2,3-Diphosphoglyceric Acid

JLZ is the FDA product code for nadh, phosphoglycerate mutase, atp (u.v.) 2,3-diphosphoglyceric acid. It is a Class I device, regulated under 21 CFR 862.1255 and reviewed by the Clinical Chemistry panel. Devices under JLZ reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.

Classification

FieldValue
Device nameNadh, Phosphoglycerate Mutase, Atp (U.V.) 2,3-Diphosphoglyceric Acid
Device classClass I
Regulation21 CFR 862.1255
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k) exempt

Recalls for JLZ devices

FDA recall records list no recalls for product code JLZ.

Frequently asked questions

What is FDA product code JLZ?

JLZ is the FDA product code for nadh, phosphoglycerate mutase, atp (u.v.) 2,3-diphosphoglyceric acid. It is a Class I device, regulated under 21 CFR 862.1255 and reviewed by the Clinical Chemistry panel.

What device class is JLZ?

Class I, regulation 21 CFR 862.1255. Typical premarket route: 510(k) exempt.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times